Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis

Treatments for NAFLD: State of Art

(2021) Alessandro Mantovani et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes

(2021) Stefano Ciardullo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Target Therapies for NASH/NAFLD: From the Molecular Aspect to the Pharmacological and Surgical Alternatives

(2021) Michele Finotti et al.   Journal of Personalized Medicine

Complications, morbidity and mortality of nonalcoholic fatty liver disease

(2020) Alessandro Mantovani et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease

(2020) Jung Il Lee et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map

(2020) Jai Kumar et al.   DIGESTIVE AND LIVER DISEASE

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

(2018) Chris Estes et al.   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease – A global public health perspective

(2018) Zobair M. Younossi   JOURNAL OF HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Statin use and non-alcoholic steatohepatitis in at risk individuals

(2015) Paola Dongiovanni et al.   JOURNAL OF HEPATOLOGY

Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals

(2014) Catherine E. de Keyser et al.   DIGESTIVE AND LIVER DISEASE

Non-cardiovascular effects associated with statins

(2014) C. S. Desai et al.   BMJ-British Medical Journal

Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease

(2013) Ebenezer T. Oni et al.   ARCHIVES OF MEDICAL RESEARCH

Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property

(2012) Hideyuki Hyogo et al.   DIGESTIVE AND LIVER DISEASE

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study

(2012) Takashi Nakahara et al.   HEPATOLOGY RESEARCH

Lipid Targets During Statin Treatment in Dyslipidemic Patients Affected by Nonalcoholic Fatty Liver Disease

(2011) Lorenzo Maroni et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study

(2011) Hideyuki Hyogo et al.   HEPATOLOGY RESEARCH

Hepatotoxicity Fears Contribute to Underutilization of Statin Medications by Primary Care Physicians

(2010) Fadi S. Rzouq et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Effects of high-dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism

(2010) C. Pramfalk et al.   JOURNAL OF INTERNAL MEDICINE

A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis

(2009) Austin Nelson et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

(2008) Hideyuki Hyogo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL